These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1465521)

  • 21. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
    Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
    Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive effect of once daily sustained release isradipine: a placebo controlled cross-over study.
    Arzilli F; Gandolfi E; Del Prato C; Innocenti P; Ponzanelli F; Caiazza A; Ghisoni F; Saba P; Giuntoli F; Borgnino C
    Eur J Clin Pharmacol; 1993; 44(1):23-5. PubMed ID: 8436150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hypertensive crisis in outpatients with sublingual isradipine].
    Saragoça MA; Portela JE; Plavnik F; Ventura RP; Lotaif LD; Ramos OL
    Arq Bras Cardiol; 1992 Mar; 58(3):233-6. PubMed ID: 1340204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring.
    Podjarny E; Korzets Z; Bernheim J
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.
    Ranieri G; Filitti V; Andriani A; Bonfantino MV; Lamontanara G; Cavallo A; Milani M; De Cesaris R
    Cardiovasc Drugs Ther; 1996 May; 10(2):119-23. PubMed ID: 8842503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of slow-release oral isradipine in moderate-to-severe hypertension with add-on spirapril.
    Abarquez RF; Sy RG; Castillo RR
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):77S-79S. PubMed ID: 8466734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. At equipotent doses, isradipine is better tolerated than amlodipine in patients with mild-to-moderate hypertension: a double-blind, randomized, parallel-group study.
    Hermans L; Deblander A; De Keyser P; Scheys I; Lesaffre E; Westelinck KJ
    Br J Clin Pharmacol; 1994 Oct; 38(4):335-40. PubMed ID: 7833223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
    Widimský J; Sirotiaková J
    Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring.
    Fogari R; Malacco E; Tettamanti F; Gnemmi AE; Milani M
    Br J Clin Pharmacol; 1993 Jan; 35(1):51-4. PubMed ID: 8448068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and dynamic response of plain and slow release isradipine formulations in moderately hypertensive patients.
    Christensen HR; Simonsen K; Kampmann JP
    Pharmacol Toxicol; 1993 Nov; 73(5):279-84. PubMed ID: 8115311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive effect of isradipine on ambulatory and casual blood pressure.
    Fitscha P; Meisner W
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):67S-69S. PubMed ID: 8466731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of isradipine in black patients with very severe hypertension. 24-hour ambulatory blood pressure monitoring and echocardiographic evaluation.
    Skoularigis J; Weinberg J; Strugo V; Davis J; Skudicky D; Zambakides C; Sareli P
    Am J Hypertens; 1994 Dec; 7(12):1058-64. PubMed ID: 7702799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of isradipine on the central and cerebral hemodynamics of patients with circulatory encephalopathy and hypertension].
    Lepakhin VK; Ivleva AIa; Romashova MF; Udotova SA; Zubovskiĭ LG
    Eksp Klin Farmakol; 1992; 55(6):24-6. PubMed ID: 1305868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isradipine: a slow-release formulation given once daily controls blood pressure for 24 h.
    Holmes DG
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):74S-76S. PubMed ID: 8466733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring.
    Perticone F; Pugliese F; Marcantonio AM; Cloro C; Maio R; Mattioli PL
    Clin Cardiol; 1995 Jul; 18(7):401-7. PubMed ID: 7554545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.